Article
IL17RA gene variants and anti-TNF response among psoriasis patients.
The pharmacogenomics journal - 1 Jan 2018
Batalla A, Coto E, Gómez J, Eirís N, González-Fernández D, Gómez-De Castro C, Daudén E, Llamas-Velasco M, Prieto-Perez R, Abad-Santos F, Carretero G, García F S, Godoy Y B, Cardo L F, Alonso B, Iglesias S, Coto-Segura P
Abstract excerpt
Polymorphisms at genes encoding proteins involved in the pathogenesis of psoriasis (Psor) or in the mechanism of action of biological drugs could influence the treatment response. Because the interleukin (IL)-17 family has a central role in the pathogenesis of Psor, we hypothesized that IL17RA variants could influence the response to anti-TNF drugs among Psor patients. To address this issue we performed a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
